Earnings Feed
Start Free
Home/Filings/4/0001181431-08-066063
4//SEC Filing

INDEVUS PHARMACEUTICALS INC 4

Accession 0001181431-08-066063

CIK 0000854222operating
View on SEC.govCompany Profile

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 5:10 PM ET

Size

12.4 KB

Accession

0001181431-08-066063

Insider Transaction Report

Form 4
Period: 2008-12-04
INDEVUS PHARMACEUTICALS INCIDEV
MORVILLE MALCOLM
Director
Transactions
  • Award

    Stock Option (right to buy)

    2008-12-04+31,000→ 31,000 total
    Exercise: $6.19Exp: 2010-06-10→ Common Stock, $.001 par value per share (31,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2008-12-04−31,000→ 0 total
    Exercise: $6.19Exp: 2009-06-10→ Common Stock, $.001 par value per share (31,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2008-12-04−5,000→ 0 total
    Exercise: $3.63Exp: 2009-03-17→ Common Stock, $.001 par value per share (5,000 underlying)
  • Award

    Stock Option (right to buy)

    2008-12-04+5,000→ 5,000 total
    Exercise: $3.63Exp: 2010-03-17→ Common Stock, $.001 par value per share (5,000 underlying)
Footnotes (3)
  • [F1]All of the reported transactions involved the amendment of outstanding stock options to extend the respective expiration dates from 6/10/2009 to 6/10/2010 and from 3/17/2009 to 3/17/2010; such extensions are considered by the Securities and Exchange Commission to be cancellations of the current stock options.
  • [F2]Prior to the extension of the current stock option, such stock option was fully exercisable.
  • [F3]This stock option is fully exercisable as of the date of this report.

Documents

1 file

Issuer

INDEVUS PHARMACEUTICALS INC

CIK 0000854222

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000854222

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 5:10 PM ET
Size
12.4 KB
View on SEC.gov